An insight into future treatments for MM and their complications
Renal complications in multiple myeloma - characteristics and treatment
ENDEAVOUR, ASPIRE and TOURMALINE-MM1 trial results for multiple myeloma
Identification of high-risk disease using Molecular profiling by Mymap
Can daratumumab be used to treat refractory MM?